Skip to main content

Month: January 2021

First National Corporation Reports Fourth Quarter 2020 Financial Results

STRASBURG, Va., Jan. 29, 2021 (GLOBE NEWSWIRE) — First National Corporation (the “Company” or “First National”) (NASDAQ: FXNC), the bank holding company of First Bank (the “Bank”), reported unaudited consolidated net income of $3.2 million, or $0.65 per diluted share, for the fourth quarter of 2020, which resulted in a return on average assets of 1.31% and a return on average equity of 15.03%. This compares to net income of $2.7 million, or $0.55 per diluted share, and a return on average assets of 1.36% and a return on average equity of 14.10% for the fourth quarter of 2019. Recovery of loan losses of $200 thousand and provision for loan losses of $250 thousand were included in net income for the three-month periods ending December 31, 2020 and 2019, respectively.For the year ending December 31, 2020, net income totaled $8.9 million,...

Continue reading

Form 8.3 – [Scapa Group plc] – (CGWL)

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Amerant Bancorp Inc. Reports Fourth Quarter and Full-Year Results

CORAL GABLES, Fla., Jan. 29, 2021 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB and AMTBB) (the “Company” or “Amerant”) today reported net income of $8.5 million in the fourth quarter of 2020, compared to net income of $1.7 million reported in the third quarter of 2020 and net income of $13.5 million reported in the fourth quarter of 2019. Net loss for the full-year 2020 was $1.7 million, compared to net income of $51.3 million for the full-year 2019. Net loss for the full-year 2020 was primarily driven by $88.6 million in provision for loan losses during the period. Operating income was $7.5 million in the fourth quarter of 2020, compared to $11.5 million in the third quarter of 2020 and $14.8 million in the fourth quarter of 2019. Operating income was $57.3 million in the full-year 2020, compared to $58.3 million in the...

Continue reading

Bombardier Closes Sale of its Transportation business to Alstom

Net proceeds to Bombardier of ~$3.6 billion, including ~$600 million in Alstom sharesProceeds strengthen liquidity and will allow the Company to begin debt paydown1; Pro-forma net debt as of December 31, 2020 ~$4.7 billion2 Completes Bombardier’s repositioning as a pure-play business jet companyAll amounts in this press release are in U.S. dollars unless otherwise indicated. Amounts in EUR in this press release are converted to USD at an exchange rate of 1.22, except for certain transaction cash proceeds fixed at an exchange rate of 1.17.MONTREAL, Jan. 29, 2021 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) confirmed today the closing of the previously announced sale of its Transportation business to Alstom.Total proceeds to the vendors after the deduction of debt-like items and transferred liabilities are $6.0 billion3. After deducting...

Continue reading

Bombardier conclut la vente de son secteur d’activité Transport à Alstom

Produit net versé à Bombardier d’environ 3,6 milliards $, incluant environ 600 millions $ en actions AlstomProduit renforçant les liquidités et permettant à Bombardier de commencer à rembourser sa dette1; dette nette pro-forma d’environ 4,7 milliards $2au 31 décembre 2020Repositionnement de Bombardier comme entreprise axée sur les avions d’affaires complétéTous les montants de ce communiqué de presse sont exprimés en dollars américains, à moins d’indication contraire. Les montants en euros de ce communiqué de presse ont été convertis en dollars américains à un taux de change de 1,22, à l’exception de certains produits d’opération en espèces convertis à un taux de change fixe de 1,17.MONTRÉAL, 29 janv. 2021 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) a confirmé aujourd’hui la clôture de la vente antérieurement annoncée de son...

Continue reading

Alstom SA: A transformational step for Alstom: completion of the acquisition of Bombardier Transportation

      A transformational step for Alstom: completion of the acquisition of Bombardier TransportationCreation of a global mobility leader committed to respond to the increasing need for greener transportation worldwideComprehensive product portfolio, unparalleled R&D innovation capabilities, extensive commercial reach, leveraging the many complementarities of the two groups75,000 diverse and experienced employees in 70 countries to serve clients globallyStrengthened long-term shareholding profile and value creation for all stakeholders                                                                                      29 January 2021 – Alstom announces today the completion of the acquisition of Bombardier Transportation. Leveraging on its clear Alstom in Motion strategy and its strong operational fundamentals and financial trajectory,...

Continue reading

ALSTOM SA: Une étape transformante pour Alstom : réalisation de l’acquisition de Bombardier Transport

 Une étape transformante pour Alstom :  réalisation de l’acquisition de Bombardier TransportCréation d’un leader mondial de la mobilité, engagé à répondre à la demande croissante en matière de transport plus vert dans le monde entierUn portefeuille complet de produits, des capacités d’innovation en R&D sans précédent, une présence commerciale élargie, mobilisant les nombreuses complémentarités entre les deux groupes75 000 employés expérimentés et venant de tous les horizons dans 70 pays au service des clients à travers le mondeUn profil d’actionnariat de long-terme renforcé et de la valeur créée pour toutes les parties prenantes 29 janvier 2021 – Alstom annonce aujourd’hui la réalisation de l’acquisition de Bombardier Transport. Tirant parti de sa stratégie claire Alstom in Motion ainsi que de ses fondamentaux opérationnels et de...

Continue reading

Yunji to Launch First-Ever Private Label Food Brand Li Ba Tian

HANGZHOU, China, Jan. 29, 2021 (GLOBE NEWSWIRE) — Yunji Inc. (“Yunji” or the “Company”) (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced the introduction of its private label food brand, Li Ba Tian. The Company plans to start selling high-quality food products under the Li Ba Tian brand on February 2, 2021. The introduction of Li Ba Tian marks the Company’s first-ever addition of a private label food brand to its network of private label brands, emerging brands, and joint-venture brands, further showcasing the strength of its differentiated product supply chain.Recognizing users’ increasing demands for quality food, particularly children’s food, the Company decided to launch Li Ba Tian. The first product under the Li Ba Tian private label food brand is a high-quality grilled sausage with no excessive...

Continue reading

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test

BETHLEHEM, Pa., Jan. 29, 2021 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced its OMNIgene®·ORAL (OM-505) saliva collection kit, a product of subsidiary DNA Genotek, was included in the Emergency Use Authorization (EUA) granted to Ambry Genetics for use in its Ambry COVID-19 RT-PCR saliva test. OMNIgene®·ORAL will be utilized for non-invasive and self-administered collection and stabilization of saliva for the detection and identification SARS CoV-2 RNA. This is the eighth EUA to include a collection device from the Company’s DNA Genotek subsidiary.Ambry Genetics will utilize OMNIgene®·ORAL with the test authorized by this EUA to provide COVID-19 viral infection testing for population...

Continue reading

Extension of Offers for Subscription

Downing FOUR VCT plcLEI: 21380035MV1VRYEXPR9529 January 2021Extension of Offers for SubscriptionThe Directors of Downing FOUR VCT plc announce an extension of the Offers for Subscription which opened on 27 February 2020 (“Offers”), in respect of its Generalist and Healthcare Share classes. The Offers had previously been scheduled to close on 31 January 2021 but have now been extended to 3p.m. on 19 February 2021 (unless previously fully subscribed or further extended).

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.